TRENTON – A bill which would allow pharmacies in New Jersey to sell hypodermic syringes and needles without a prescription was approved by the state Senate Health, Human Services and Senior Citizens Committee Thursday by a vote of 6-2.
“While there’s no question that New Jersey needs to do a better job for the people in our state suffering from substance abuse, restricting access to sterile syringes only succeeds in driving drug use underground, and encourages dangerous health practices, such as sharing needles,” said state Sen. Vitale, D-Middlesex and vice chair of the Senate Health Committee.
“Allowing the sale of sterile syringes without a prescription does not condone drug use, but it does reduce the spread of blood-borne diseases such as HIV/AIDS and hepatitis C. It’s smart legislation which follows science to help address the HIV/AIDS epidemic in the Garden State.”
The bill, S-958, would permit licensed pharmacies to sell hypodermic needles and syringes, as well as other instruments adapted for the administration of drugs by injection, to individuals without a prescription in the Garden State. Under the bill, a person would have to be over 18 years old to purchase sterile needles in a pharmacy, and would be limited to 10 or fewer needles per purchase.
The supply of needles would be kept behind the sales counter, and pharmacists would, at the time of sale, provide people with information printed in English and Spanish concerning the safe disposal of needles, including local disposal locations or a telephone to call for that information, and information concerning drug addiction treatment, including a telephone number to all for assistance in obtaining treatment.
The bill would also amend current law so that individuals would be allowed to possess a hypodermic syringe or a needle without a prescription. The senators noted that the bill would also make it easier for individuals with diabetes to obtain syringes – currently, people with diabetes need a prescription to obtain syringes at the pharmacy.
“This isn’t about judging individuals who are addicted to intravenous drugs, but about slowing the spread of HIV/AIDS in the State of New Jersey,” said Vitale. “We pay an enormous societal cost for the treatment of uninsured individuals infected with HIV/AIDS or other blood-borne diseases, and many of those individuals were first exposed to those diseases through sharing needles. It’s time that we adopt smarter policies regarding the spread of these diseases, and at the same time, we can provide them with the information they need to get help with their addiction.”
The bill now heads to the full Senate for consideration.
Connect with NJTODAY.NET
Join NJTODAY.NET's free Email List to receive occasional updates delivered right to your email address!